title: Enhanced neurogenesis in organotypic cultures of rat hippocampus after transient subfield-selective excitotoxic insult induced by domoic acid.
abstract: New neurons are continuously generated in the hippocampus and may play an important role in many physiological and pathological conditions. Here we present evidence of cell proliferation and neurogenesis after a selective and transient excitotoxic injury to the hippocampal cornu ammonis 1 (CA1) area induced by low concentrations of domoic acid (DOM) in rat organotypic hippocampal slice cultures (OHSC). DOM is an excitatory amino acid analog to kainic acid that acts through glutamate receptors to elicit a rapid and potent excitotoxic response. Exposure of slice cultures to varying concentrations of DOM for 24 h induced dose-dependent neuronal toxicity that was independent of activation of classic apoptotic markers. Treatment with 2 μM DOM for 24 h caused a selective yet transient neurotoxic injury in the CA1 subfield of the hippocampus that appeared recovered after 7 days of incubation in a DOM-free medium and showed significant microgliosis but no sign of astrogliosis. The DOM insult (2 μM, 24 h) resulted in a significant upregulation of cell proliferation, as assessed by 5-bromo-2-deoxyuridine (BrdU) incorporation, and a concurrent increase of the neuronal precursor cell marker doublecortin (DCX) within the subgranular zone of the dentate gyrus and area CA1. Neurogenesis occurred primarily during the first week after termination of the DOM exposure. Our study shows that exposure of OHSC to concentrations of DOM below those required to induce permanent neurotoxicity can induce proliferation and differentiation of neural progenitor cells that may contribute to recovery from mild injury and to develop abnormal circuits relevant to disease.
authors.affiliation: Department of Biomedical Sciences, University of Prince Edward Island, Charlottetown, PEI, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Pérez-Gómez
authors.forename: R A
authors.initials: RA
authors.lastname: Tasker
mesh_terms: D000818:Animals; D000963:Antimetabolites; D017209:Apoptosis / Q000187:drug effects; D001562:Benzimidazoles; D001973:Bromodeoxyuridine; D056547:CA1 Region, Hippocampal / Q000166:cytology / Q000187:drug effects / Q000254:growth & development; D053148:Caspase 3 / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects; D004396:Coloring Agents; D004305:Dose-Response Relationship, Drug; D000089662:Doublecortin Protein; D005455:Fluorescent Antibody Technique; D005456:Fluorescent Dyes; D006624:Hippocampus / Q000166:cytology* / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism*; D007150:Immunohistochemistry; D007608:Kainic Acid / Q000031:analogs & derivatives* / Q000633:toxicity; D017628:Microglia / Q000201:enzymology / Q000378:metabolism; D055495:Neurogenesis / Q000187:drug effects*; D009467:Neuromuscular Depolarizing Agents / Q000633:toxicity*; D009924:Organ Culture Techniques; D011419:Propidium; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000963:Antimetabolites; D001562:Benzimidazoles; D004396:Coloring Agents; C000714848:Dcx protein, rat; D000089662:Doublecortin Protein; D005456:Fluorescent Dyes; D009467:Neuromuscular Depolarizing Agents; D011419:Propidium; D053148:Caspase 3; D001973:Bromodeoxyuridine; C012301:domoic acid; C017807:bisbenzimide ethoxide trihydrochloride; D007608:Kainic Acid